Profile of neuroblastoma detected by mass screening, resected after observation without treatment: Results of the Wait and See pilot study

Journal of Pediatric Surgery

Volumn 40, Issue 2, 2005, Pages 359-363

  Oue, Takaharu ^a   Inoue, Masami ^b   Yoneda, Akihiro ^b   Kubota, Akio ^b   Okuyama, Hiroomi ^b   Kawahara, Hisayoshi ^b   Nishikawa, Masanori ^b   Nakayama, Masahiro ^b   Kawa, Keisei ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

Mass screening; Neuroblastoma; Observation; Spontaneous regression

Indexed keywords

PROTEIN TYROSINE KINASE A; TUMOR MARKER;

ADOLESCENT; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER REGRESSION; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; DIPLOIDY; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; METASTASIS; NEUROBLASTOMA; OBSERVATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT PLANNING; TUMOR VOLUME;

EID: 13844271311     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2004.10.062     Document Type: Article

References (10)

1. T. Sawada, T. Matsumura, and H. Kawakatsu Long-term effects of mass screening for neuroblastoma in infancy Am. J. Pediatr. Hematol./Oncol. 13 1991 3 7
2. T. Matsumura, T. Shikata, and T. Sawada Treatment modality for neuroblastoma infants in Japan: retrospective analysis and future directions Proceedings of the 31st American Society of Clinical Oncology J. Clin. Oncol. 14 1995 456
3. S. Suita, Y. Zaizen, and Y. Sera Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan J. Pediatr. Surg. 31 1996 555 558
4. K. Yamamoto, R. Hanada, and A. Kikuchi Spontaneous regression of localized neuroblastoma detected by mass screening J. Clin. Oncol. 16 1998 1265 1269
5. H. Nishihira, Y. Toyoda, and Y. Tanaka Natural course of neuroblastoma detected by mass screening: 5-year prospective study at a single institution J. Clin. Oncol. 18 2000 3012 3017
6. A. Yoneda, T. Oue, and K. Imura Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study Med. Pediatr. Oncol. 36 2001 160 162
7. A.E. Evans, G.J. D'Angio, and J. Randolph A proposed staging for children with neuroblastoma. Children's Cancer Study Group A Cancer 27 1995 374 378
8. H. Shimada, J. Chattern, and H.W. Newton Histologic prognostic factors in neuroblastic tumors; Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastoma J. Natl. Cancer Inst. 73 1984 405 416
9. T. Iwanaka, M. Arai, and M. Ito Surgical treatment for abdominal neuroblastoma in the laparoscopic era Surg. Endosc. 15 2001 751 754
10. T. Tanaka, T. Sugimoto, and T. Sawada Prognostic discrimination among neuroblastomas according to Ha-ras/Trk A gene expression: a comparison of the profiles of neuroblastomas detected clinically and those detected through mass screening Cancer 83 1998 1626 1633